Skip to main content
. Author manuscript; available in PMC: 2020 Dec 28.
Published in final edited form as: Am J Prev Med. 2020 Jun 9;59(2):211–218. doi: 10.1016/j.amepre.2020.03.010

Table 3.

Health, Budgetary, and Economic Outcomes With Sodium Reduction Policy by Age and Sex Subgroups

Difference attributable to sodium reduction policy
Outcomes Ages 35–64 years Ages ≥65 years Men Women
At 10 years
 Individuals SBP ≥140 mmHg (millions) −4.0 −2.9 −3.9 −3.0
 Individuals with SBP 120–139 mmHg (millions) −6.8 −1.3 −4.7 −3.4
Over 10 years
 Person-years above goal (millions) −26 −16 −24 −18
 Incident MI (thousands) −92 −127 −156 −63
 Incident strokea (thousands) −65 −220 −147 −137
 Incident CVD events (thousands) −265 −630 −530 −365
 Incident CVD death (thousands) −39 −214 −157 −95
 CVD costs, total (billions $) −12 −25 −22 −15
 Total productivity (billions $) 5 13 12 6

Note: The Incident CVD events rows combine incident MI, incident stroke, incident hospitalization for congestive heart failure, onset of angina pectoris, and onset of intermittent claudication. All costs are in undiscounted 2017 U.S. dollars.

a

Incident stroke includes incident ischemic and hemorrhagic stroke.

CVD, cardiovascular disease; MI, myocardial infarction; SBP, systolic blood pressure.